<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00667849</url>
  </required_header>
  <id_info>
    <org_study_id>EX-TIB-0907</org_study_id>
    <nct_id>NCT00667849</nct_id>
  </id_info>
  <brief_title>Trial to Evaluate UltraSound in the Treatment of Tibial Fractures</brief_title>
  <acronym>TRUST</acronym>
  <official_title>Trial to Evaluate UltraSound in the Treatment of Tibial Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bioventus LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Advances Through Research and Information Translation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bioventus LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of low-intensity, pulsed ultrasound on
      tibial fractures treated with intramedullary nailing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, placebo controlled, clinical trial to evaluate the safety and efficacy of
      low-intensity, pulsed ultrasound, applied to tibial fractures treated with intramedullary
      nailing.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was terminated due to futility
  </why_stopped>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in the SF-36 Physical Component Summary (PCS) Score of the Short Form-36 (SF-36)</measure>
    <time_frame>Over 365 days</time_frame>
    <description>Assessments at baseline and 6 post baseline time points/ mixed effects repeated measure single point estimate. Range= -100 worst, 0 best</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time (Days) to Radiographic Healing of Tibial Fractures</measure>
    <time_frame>over 365 days</time_frame>
    <description>Days from randomization to day of x-ray assessed healed or, if not healed, day of premature withdrawal/study termination or day 365 (end of study visit)/ Kaplan-Meier</description>
  </primary_outcome>
  <other_outcome>
    <measure>Treatment Compliance</measure>
    <time_frame>Treatment period: Days from randomization to day of x-ray assessed healed or, if not heal, day of premature withdrawal/study termination or day 365 (end of study visit)</time_frame>
    <description>The percent of subjects who used the device greater than or equal to 18 minutes per day over 80% of the days in their treatment period.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">501</enrollment>
  <condition>Tibial Fractures</condition>
  <arm_group>
    <arm_group_label>Exogen 4000+</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single arm, Exogen 4000+</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Single arm, sham (identical device with the exception of administration of ultrasound).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exogen 4000+</intervention_name>
    <description>Low-intensity pulsed ultrasound (LIPUS)</description>
    <arm_group_label>Exogen 4000+</arm_group_label>
    <other_name>Exogen Bone Healing System - 4000+ series</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>sham device identical to active device with the exception of administration of ultrasound</description>
    <arm_group_label>Sham</arm_group_label>
    <other_name>Single arm, sham of the Exogen 4000+</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females age 18 years or older

          -  Have an open or closed tibial fracture amenable to intramedullary nail fixation

        Exclusion Criteria:

          -  Tibial fracture associated with a vascular injury requiring repair

          -  Pilon fractures

          -  Tibial fractures that extend into the joint and require reduction

          -  Pathologic fractures â€¢ Bilateral tibial fractures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohit Bhandari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Francisco General/Dept of Orthopedic Surgery</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Orthopedic Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OrthoIndy</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>50436</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Maine Medical Center</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Insall Scott Kelly Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Hospital System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedic Specialtiy Associates</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver Coastal Health</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QE II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2008</study_first_submitted>
  <study_first_submitted_qc>April 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2008</study_first_posted>
  <results_first_submitted>September 24, 2015</results_first_submitted>
  <results_first_submitted_qc>November 4, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 8, 2015</results_first_posted>
  <last_update_submitted>November 4, 2015</last_update_submitted>
  <last_update_submitted_qc>November 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tibia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Exogen 4000+</title>
          <description>Single arm, Exogen 4000+
Low-intensity pulsed ultrasound (LIPUS)</description>
        </group>
        <group group_id="P2">
          <title>Sham</title>
          <description>Single arm, sham (identical to active device with the exception of administration of ultrasound)
Sham: sham device identical to active device with the exception of administration of ultrasound</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="250"/>
                <participants group_id="P2" count="251"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="142"/>
                <participants group_id="P2" count="130"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="108"/>
                <participants group_id="P2" count="121"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exogen 4000+</title>
          <description>Single arm, Exogen 4000+
Low-intensity pulsed ultrasound (LIPUS)</description>
        </group>
        <group group_id="B2">
          <title>Sham</title>
          <description>Single arm, sham (identical to active device with the exception of administration of ultrasound).
Sham: sham device identical to active device with the exception of administration of ultrasound</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="250"/>
            <count group_id="B2" value="251"/>
            <count group_id="B3" value="501"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="244"/>
                    <measurement group_id="B2" value="239"/>
                    <measurement group_id="B3" value="483"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.1" spread="13.2"/>
                    <measurement group_id="B2" value="39.1" spread="14.6"/>
                    <measurement group_id="B3" value="38.3" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="169"/>
                    <measurement group_id="B2" value="176"/>
                    <measurement group_id="B3" value="345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="168"/>
                    <measurement group_id="B2" value="166"/>
                    <measurement group_id="B3" value="334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in the SF-36 Physical Component Summary (PCS) Score of the Short Form-36 (SF-36)</title>
        <description>Assessments at baseline and 6 post baseline time points/ mixed effects repeated measure single point estimate. Range= -100 worst, 0 best</description>
        <time_frame>Over 365 days</time_frame>
        <population>Full Analysis Set (FAS) is all subjects randomized with at least one post treatment set of adjudicated x-rays.</population>
        <group_list>
          <group group_id="O1">
            <title>Exogen 4000+</title>
            <description>Single arm, active Exogen 4000+ Low-intensity pulsed ultrasound (LIPUS)</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Single arm, sham (identical to active device with the exception of administration of ultrasound)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the SF-36 Physical Component Summary (PCS) Score of the Short Form-36 (SF-36)</title>
          <description>Assessments at baseline and 6 post baseline time points/ mixed effects repeated measure single point estimate. Range= -100 worst, 0 best</description>
          <population>Full Analysis Set (FAS) is all subjects randomized with at least one post treatment set of adjudicated x-rays.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="241"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.9" lower_limit="-8.0" upper_limit="-5.9"/>
                    <measurement group_id="O2" value="-7.5" lower_limit="-8.6" upper_limit="-6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time (Days) to Radiographic Healing of Tibial Fractures</title>
        <description>Days from randomization to day of x-ray assessed healed or, if not healed, day of premature withdrawal/study termination or day 365 (end of study visit)/ Kaplan-Meier</description>
        <time_frame>over 365 days</time_frame>
        <population>Full Analysis Set (FAS) is all subjects randomized with at least one post treatment set of adjudicated x-rays.</population>
        <group_list>
          <group group_id="O1">
            <title>Exogen 4000+</title>
            <description>Single arm, active Exogen 4000+ Low-intensity pulsed ultrasound (LIPUS)</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Single arm, sham (identical to active device with the exception of administration of ultrasound)
Sham: device identical to active device with the exception of administration of ultrasound</description>
          </group>
        </group_list>
        <measure>
          <title>Time (Days) to Radiographic Healing of Tibial Fractures</title>
          <description>Days from randomization to day of x-ray assessed healed or, if not healed, day of premature withdrawal/study termination or day 365 (end of study visit)/ Kaplan-Meier</description>
          <population>Full Analysis Set (FAS) is all subjects randomized with at least one post treatment set of adjudicated x-rays.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="241"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130" lower_limit="112" upper_limit="183"/>
                    <measurement group_id="O2" value="133" lower_limit="115" upper_limit="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Treatment Compliance</title>
        <description>The percent of subjects who used the device greater than or equal to 18 minutes per day over 80% of the days in their treatment period.</description>
        <time_frame>Treatment period: Days from randomization to day of x-ray assessed healed or, if not heal, day of premature withdrawal/study termination or day 365 (end of study visit)</time_frame>
        <population>FAS with compliance data (subjects who returned the device)</population>
        <group_list>
          <group group_id="O1">
            <title>Exogen 4000+</title>
            <description>Single arm, Exogen 4000+
Low-intensity pulsed ultrasound (LIPUS)</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Single arm, sham (identical to active device with the exception of administration of ultrasound)
sham: sham device identical to active device with the exception of administration of ultrasound</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Compliance</title>
          <description>The percent of subjects who used the device greater than or equal to 18 minutes per day over 80% of the days in their treatment period.</description>
          <population>FAS with compliance data (subjects who returned the device)</population>
          <units>percentage of compliant participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="215"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.6"/>
                    <measurement group_id="O2" value="42.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 2 years</time_frame>
      <desc>no standardized coding dictionary used</desc>
      <group_list>
        <group group_id="E1">
          <title>Exogen 4000+</title>
          <description>Single arm, active Exogen 4000+ ultrasound bone healing system
Low-intensity pulsed ultrasound (LIPUS)</description>
        </group>
        <group group_id="E2">
          <title>Sham</title>
          <description>Single arm, sham (identical to active device with the exception of administration of ultrasound)
Sham: device identical to active device with the exception of administration of ultrasound</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>acute chest pain</sub_title>
                <description>abnormal troponin level and nausea Resulted in hospitalization Not related to device</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>sternal wire closure disruption</sub_title>
                <description>resulted in hospitalization</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>cough, vomiting, leukocytosis, increased troponin</sub_title>
                <description>possible gastroenteritis resulted in hospitalization</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <description>Resulted in hospitalization Not related to device</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection, tissue</sub_title>
                <description>Resulted in hospitalization, was a life threatening situation, necessitated medical surgical intervention to preclude primary impairment of body function or permanent damage to a body structure.
Not related to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>infection tissue</sub_title>
                <description>cellulitis; resulted in hospitalization</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Tendonitis</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>tendonitis of hip; resulted in hospitalization</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal dysfunction (creatinine 2x BL level</sub_title>
                <description>Resulted in hospitalization Not related to device</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Broken screw</sub_title>
                <description>Resulted in hospitalization Not related to device</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="98" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="97" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Edema</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Edema of left lower extremity</description>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="250"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other, not listed on AE form</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="250"/>
                <counts group_id="E2" events="24" subjects_affected="21" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="250"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection, tissue</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="250"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="250"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>accident/fall</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-union</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="250"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Other local event</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="250"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="58" subjects_affected="48" subjects_at_risk="250"/>
                <counts group_id="E2" events="63" subjects_affected="49" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash/redness at treated area</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="250"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Poor Compliance: Protocol defined compliance as â‰¥18 minutes use per day. Devices have a treatment monitor that showed average compliance of 42.3% (sham) and 44.6% (active) in 80% of treatment days. Poor treatment adherence confounds results.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Peter Heeckt, MD (CMO)</name_or_title>
      <organization>Bioventus LLC</organization>
      <phone>1-800-396-4325</phone>
      <email>peter.heeckt@bioventusglobal.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

